Published in Cancer Weekly, June 10th, 2008
"Results of the QLQ-C30 were compared with Swedish norm values. A majority of the patients reported concerns related to health before as well as one year after SCT, recorded by both...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.